The Technical Accelerator Award supports research and development of vaccines and therapeutics to prevent and alleviate the infection, progression, and spread of endemic or emerging infectious diseases in low- and middle-income countries. The amount of support is KRW 500 million per project, and at least one Korean corporation must be included as a lead institution or public research organization.

For more detailed information, please refer to the attached document.